Significance of measuring anthropometric and atherogenic indices in patients with polycystic ovary syndrome

BMC Endocrine Disorders

Table 3 Relationship between anthropometric measurements, atherogenic indices, and insulin Profile in the Study Group

	N (248)	Fasting Insulin (mU/L)		60 min Insulin (mU/L)
	N (248)	R	p	r	p
Weight (kg)		0.336	< 0.001	0.406	< 0.001
Waist Circumference (cm)		0.321	< 0.001	0.475	< 0.001
Hip Circumference (cm)		0.312	< 0.001	0.527	< 0.001
BMI (kg/m²)		0.345	< 0.001	0.396	< 0.001
WHR		0.132	0.038	0.161	0.011
WHtR		0.331	< 0.001	0.464	< 0.001
BAI (%)		0.313	< 0.001	0.497	< 0.001
VAI		0.112	0.079	0.245	< 0.001
LAP		0.187	0.003	0.432	< 0.001
BRI		0.331	< 0.001	0.456	< 0.001
ABSI		-0.015	0.817	0.102	0.109
Castelli’s Risk Index-I		0.160	0.012	0.290	< 0.001
Castelli’s Risk Index-II		0.134	0.036	0.290	< 0.001
AIP		0.116	0.068	0.170	0.007
AC		0.160	0.012	0.290	< 0.001
LCI		0.129	0.042	0.388	< 0.001
TG/HDL-C		0.116	0.068	0.219	< 0.001
METS-IR		0.364	< 0.001	0.392	< 0.001
TyG Index		0.105	0.099	0.268	< 0.001
TyG-BMI		0.342	< 0.001	0.430	< 0.001
TyG- Waist Circumference Index		0.292	< 0.001	0.539	< 0.001

BMI: Body mass index, WHtR: Waist-height ratio, BAI: Body adiposity index, BRI: Body Roundness Index, WHR: Waist-to-hip ratio, VAI: Visceral Adiposity Index, LAP: Lipid Accumulation Product, ABSI: A Body Shape Index, HDL: High-density lipoprotein, AIP: Atherogenic risk of plasma, AC: atherogenic coefficient, TyG Index: triglyceride glucose index, TyG-BMI: triglyceride glucose-body mass index, LCI: lipoprotein combined index, TG/HDL-C: Triglycerides to HDL-cholesterol ratio. Correlation coefficients given in italics were calculated using Spearman’s rank correlation test.

ISSN: 1472-6823